The mutation rate of TERT promoter was lower if compared to a Mittle-European study [45] which found TERT mutations in 55% of the tumor samples with no effect on OS or association with pathologic features of aggressiveness as otherwise reported [25, 26, 24, 46, 47]. The gene discussed is TERT; the disease is neoplasm.